CXCL14 and central nervous system cancer: Regarding the clinical implications of our results, our findings about CXCL14 expression in glioma datasets support a view of CXCL14 tagging the most aggressive tumors (IV grade versus other grades), subtypes (mesenchymal and classical versus proneural), regions (leading edge of the tumors and infiltrating tumor areas), and G-CIMP status (NON G-CIMP vs G-CIMP).